Gene analysis for Duchenne/Becker muscular dystrophy

Gene analysis for Duchenne/Becker muscular dystrophy - Gene analysis for Duchenne/Becker muscular dystrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005735

Enrollment

200

Registered

2011-09-01

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne/Becker muscular dystrophy

Interventions

the dystrophin gene analysis of genemic DNA and/or mRNA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are suspected of DMD/BMD based on their clinical symptoms. Female whose family member(s) is(are) DMD/BMD patient(s).

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
detection of mutation in the dystrophin gene by genomic DNA and mRNA analysis	—

Countries

Japan

Contacts

Public ContactHiroyuki AWANO

Kobe University Graduate School of Medicine Pediatrics

awahiro@med.kobe-u.ac.jp078-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026